Brind.

Gallup Survey Shows GLP-1 Drug Usage Rises to 11% Among Adults

1 report, 1 independent Updated Oct 7
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Breitbart News published an article featuring recent survey results from Gallup. The analysis found that the percentage of American adults taking GLP-1 drugs for weight loss rose to 11 percent in 2026, up from 3 percent in 2024. Dr. Michael Burgess, an adviser at RX Border Defense, stressed concerns regarding compounded, non-FDA-approved copies of these drugs that may be imported overseas and lack proper standards.

From breitbart.com

Why it matters

Some supportBrind's analysis of the reports

The significant increase in GLP-1 usage reflects a growing consumer demand for weight loss treatments. However, the reported presence of non-FDA-approved compounded versions raises concerns about drug supply integrity and consumer safety within the healthcare market.

From breitbart.com

Who's involved

  • Breitbart NewsAmerican news and opinion website that featured the survey findings
  • GallupAmerican analytics and advisory company that conducted the public opinion survey

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped